Source: Annual Congress 2003 - Airway obstruction
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Demir, N. Koc, H. Ikitimur, F. Toker, N. Yildirim (Istanbul, Turkey). Dysinapsis in COPD and ASTHMA. Eur Respir J 2003; 22: Suppl. 45, 2673

Member's Comments

No comment yet.

Related content which might interest you: A MULTILATERAL APPROACH TO COPD COMORBIDITIES Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 TREATMENT-RELATED DETERMINANTS OF THE RESPIRATORY MICROBIOME IN COPD Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020 EOSINOPHIL COUNT AND FeNO AS PREDICTORS OF EXACERBACTIONS IN COPD Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 BODE INDEX IN DIFFERENT PHENOTYPES OF COPD Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 COPD DIAGNOSIS: DIFFERENCES ACCORDING GENDER Source: Virtual Congress 2021 – Primary care organisation and epidemiology Year: 2021 DOES THE BENEFIT FROM PULMONARY REHABILITATION DIFFER BETWEEN PHENOTYPES IN COPD? Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020 THE EFFECT OF TIOTROPIUM ON EXACERBATIONS AND AIRFLOW IN PATIENTS WITH COPD. Source: Eur Respir J 2006; 27: 1076 Year: 2006 ARE THERE DIFFERENCES IN EXERCISE CAPACITY BY GENDER IN COPD PATIENTES? Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 PERCEPTION OF CAREGIVERS ON THE CARE OF PATIENTS WITH COPD IN USE OF LTOT Source: International Congress 2017 – Nursing practice across respiratory care pathways Year: 2017 OCCUPATIONAL EXPOSURES AND INCIDENCE OF ASTHMA OVER TWO DECADES IN THE ECRHS Source: Virtual Congress 2020 – Occupational lung diseases Year: 2020 NEUROMUSCULAR EFFICIENCY DURING EXERCISE IN COPD PATIENTS Source: International Congress 2019 – Exploring exercise responses in respiratory diseases Year: 2019 PREVALENCE OF NON TUBERCULOUS MYCOBACTERIA (NTM) IN HIGH RISK COPD PATIENTS Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021 THE POTENTIAL IMPACT OF ANAEMIA OF CHRONIC DISEASE IN COPD. Source: Eur Respir J 2006; 27: 1076 Year: 2006 EXTRARESPIRATORY SYMPTOM BURDEN IN PATIENTS HOSPITALIZED FOR A COPD EXACERBATION: IT’S NOT ONLY ABOUT RESPIRATORY SYMPTOMS Source: International Congress 2019 – Innovations in care for chronic respiratory conditions Year: 2019 RATES OF LUNG FUNCTION DECLINE DIFFERS BETWEEN COPD PHENOTYPES Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Late Breaking Abstract - RHEOLOGY AS A TOOL TO ASSESS COPD DIAGNOSIS COMPARED TO ASTHMA DIAGNOSIS, AND TO EVALUATE THE EFFICIENCY OF TREATMENTS Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 PEARL SCORE PREDICTION FOR MORTALITY IN SEVERE ACUTE COPD RE-EXACERBATION Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 BIOLOGICS SWITCH IN SEVERE EOSINOPHILIC ASTHMA Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 LIPID PEROXIDATION IN PATIENTS WITH COPD AND CHRONIC HEART FAILURE. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN DIFFERENT PHENOTYPES OF COPD Source: International Congress 2017 – Management of asthma in different situations Year: 2017